Medicine and Dentistry
Status Epilepticus
68%
Epileptic Seizure
63%
Magnetic Resonance Imaging
28%
Cardiovascular Disease
20%
Partial Seizure
18%
Epilepsy Syndromes
14%
Seizure Types
12%
Atherosclerosis
12%
Drug Resistant Epilepsy
11%
Neurology
11%
Superficial Siderosis
11%
Marfan Syndrome
11%
Synaptopathy
11%
DLG4
11%
Finger Dermatoglyphics
11%
Motor Vehicle Accident
11%
Nonbenzodiazepine
11%
Vascular Amyloidosis
11%
Paralysis
11%
Radial Nerve
11%
Epileptogenesis
11%
Health Care
11%
Electroconvulsive Therapy
11%
Epilepsy Surgery
11%
Diagnostic Accuracy
11%
Patient with Epilepsy
11%
Prevalence
11%
Treatment Response
11%
Case-Control Study
11%
Cohort Analysis
11%
Patient-Data
11%
Observational Study
11%
Prophylaxis
11%
Nonalcoholic Fatty Liver
11%
Beck Depression Inventory
11%
Outpatient
11%
Susceptibility Weighted Imaging
11%
Eslicarbazepine Acetate
11%
Brain Disease
11%
Life Expectancy
11%
Cannabis
11%
Benzodiazepine
9%
Diseases
8%
Biological Marker
8%
Fatty Liver
8%
Drug Therapy
8%
Population
7%
Coronary Artery Calcification
6%
Systematic Review
6%
Functional Magnetic Resonance Imaging
5%
Dural Ectasia
5%
Siderosis
5%
Infection
5%
COVID-19 Vaccination
5%
Side Effect
5%
Primary Prevention
5%
Quality of Life
5%
Meta-Analysis
5%
Clinical Pathway
5%
Fibrosis
5%
Computer Assisted Tomography
5%
Apoplexy
5%
Pulvinar
5%
Thalamus
5%
Clinician
5%
Neuroscience
Status Epilepticus
100%
Electroencephalography
32%
Focal Epilepsy
26%
Central Nervous System
16%
Magnetic Resonance Imaging
16%
Functional Magnetic Resonance Imaging
16%
Supplementary Motor Area
13%
Magnetoencephalography
13%
Ictal
13%
Temporal Lobe Epilepsy
11%
Beck Depression Inventory
11%
Face
11%
Seizure Types
11%
Epileptic Seizure
11%
Juvenile Myoclonic Epilepsy
11%
Eslicarbazepine Acetate
11%
Carbamazepine
11%
Cochlea
11%
Nerve Conduction
11%
Eye Movement
11%
Pathological Gambling
11%
Electroconvulsive Therapy
11%
Cotard Delusion
11%
Sodium Valproate
11%
Verbal Memory
11%
Epileptogenesis
11%
Mitochondrial Disease
11%
Learning Disabilities
11%
Locked-in Syndrome
11%
Epileptic Absence
10%
Magnetic Resonance Imaging of Brain
10%
Speech Processing
9%
Transcranial Magnetic Stimulation
7%
Low Density Lipoprotein Cholesterol
6%
Lip
5%
Tuberous Sclerosis
5%
Treatment of Epilepsy
5%
Tonic-Clonic Seizure
5%
Delusion
5%
Memory Test
5%
Neurotrauma
5%
Traumatic Brain Injury
5%
Thalamus
5%
Pharmacology, Toxicology and Pharmaceutical Science
Epileptic State
44%
Cohort Study
22%
Tolerability
18%
Focal Epilepsy
16%
Adverse Event
12%
Life Expectancy
11%
Clinical Trial
11%
Nonalcoholic Fatty Liver
11%
Perampanel
11%
Disease
11%
Prevalence
11%
Nonbenzodiazepine
11%
Alcohol Intoxication
11%
Systemic Disease
11%
Cardiovascular Disease
11%
Epileptogenesis
11%
Observational Study
11%
Cannabis
11%
Benzodiazepine
9%
Tonic Clonic Seizure
9%
Fatty Liver
8%
Biological Marker
7%
Coronary Artery Calcification
6%
Fibrosis
5%
Absence
5%